| Dual contact group |  | Single contact group |  | Coefficient^ and p-value | ||
---|---|---|---|---|---|---|---|
 | Baseline | 12 months | Net change | Baseline | 12 months | Net change |  |
All (n = 2872) |  |  |  |  |  |  |  |
Intervention | 5.78 (5.69-5.88) | 6.27 (6.15-6.39) | +0.49 | 5.82 (5.72-5.91) | 6.13 (6.03-6.24) | +0.31 | 0.02 (-0.07-0.11) p = 0.70 |
Control | 5.87 (5.77-5.97) | 5.89 (5.77-6.01) | +0.02 | 5.77 (5.67-5.87) | 5.93 (5.82-6.04) | +0.16 | |
Coefficient^ | 0.17 (0.10-0.24) , p < 0.01 |  | 0.16 (0.09-0.23), p < 0.01 |  |  | ||
Men (n = 884) | Â | Â | Â | Â | Â | ||
Intervention | 5.62 (5.46-5.78) | 6.00 (5.77-6.22) | +0.38 | 5.72 (5.57-5.88) | 6.04 (5.86-6.22) | +0.32 | 0.04 (-0.21-0.13) p = 0.64 |
Control | 5.70 (5.52-5.87) | 5.66 (5.47-5.87) | -0.04 | 5.54 (5.36-5.71) | 5.57 (5.38-5.77) | +0.03 | |
Coefficient^ | 0.25 (0.8-0.42), p < 0.01 |  | 0.16 (0.5-0.18), p < 0.01 |  |  | ||
Women (n = 1988) | Â | Â | Â | Â | Â | ||
Intervention | 5.87 (5.75-5.98) | 6.39 (6.25-6.53) | +0.52 | 5.86 (5.74-5.97) | 6.18 (6.05-6.37) | +0.32 | 0.06 (-0.06-0.18) p = 0.33 |
Control | 5.94 (5.83-6.06) | 5.98 (5.84-6.13) | +0.04 | 5.87 (5.75-5.98) | 6.08 (5.95-6.21) | +0.21 | |
Coefficient^ | 0.22 (0.13-0.31), p < 0.01 |  | 0.15 (0.07-0.24), p < 0.01 |  |  |